secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gossamer Bio, Inc. (GOSS)
CIK:        0001728117
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001728117-24-000088
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Gossamer Bio receives Nasdaq bid-price deficiency notice; deadline March 2025
-----------------------------------------------------------------------------

- Nasdaq notified Gossamer Bio that its stock failed to maintain $1.00 minimum bid for 30 consecutive business days through Sept 10, 2024.
- Company has 180 calendar days, until March 10, 2025, to regain compliance by closing at $1.00 for at least 10 consecutive business days.
- If not compliant by March 2025, may transfer to Nasdaq Capital Market for an additional 180-day cure period, subject to other standards.
- Company may consider options such as a reverse stock split but cannot guarantee it will regain compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728117/000172811724000088/0001728117-24-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728117/000172811724000088/goss-20240911.htm
  HTML page:      https://secwatch.observer/filing/0001728117-24-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer